Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Extracellular CIRP induces macrophage endotoxin tolerance through IL-6R–mediated STAT3 activation
Mian Zhou, … , Gaifeng Ma, Ping Wang
Mian Zhou, … , Gaifeng Ma, Ping Wang
Published February 6, 2020
Citation Information: JCI Insight. 2020;5(5):e133715. https://doi.org/10.1172/jci.insight.133715.
View: Text | PDF
Research Article Immunology Inflammation

Extracellular CIRP induces macrophage endotoxin tolerance through IL-6R–mediated STAT3 activation

  • Text
  • PDF
Abstract

Extracellular cold-inducible RNA-binding protein (eCIRP) is a damage-associated molecular pattern, whose effect on macrophages is not entirely elucidated. Here we identified that eCIRP promotes macrophage endotoxin tolerance. Septic mice had higher serum levels of eCIRP; this was associated with a reduced ex vivo immune response of their splenocytes to LPS. Pretreatment of macrophages with recombinant murine CIRP (rmCIRP) resulted in a tolerance to LPS stimulation as demonstrated by a reduction of TNF-α production. We found that eCIRP increased phosphorylated STAT3 (p-STAT3) in macrophages. A STAT3 inhibitor, Stattic, rescued macrophages from rmCIRP-induced tolerance by restoring the release of TNF-α in response to LPS stimulation. We discovered strong binding affinity between eCIRP and IL-6 receptor (IL-6R) as revealed by Biacore, fluorescence resonance energy transfer (FRET), and their colocalization in macrophages by immunostaining assays. Blockade of IL-6R with its neutralizing Ab inhibited eCIRP-induced p-STAT3 and restored LPS-stimulated TNF-α release in macrophages. Incubation of macrophages with rmCIRP skewed them toward an M2 phenotype, while treatment with anti–IL-6R Ab prevented rmCIRP-induced M2 polarization. Thus, we have demonstrated that eCIRP activates p-STAT3 via a novel receptor, IL-6R, to promote macrophage endotoxin tolerance. Targeting eCIRP appears to be a new therapeutic option to correct immune tolerance in sepsis.

Authors

Mian Zhou, Monowar Aziz, Naomi-Liza Denning, Hao-Ting Yen, Gaifeng Ma, Ping Wang

×

Figure 4

Identification of IL-6R as a potentially novel receptor of eCIRP in macrophages.

Options: View larger image (or click on image) Download as PowerPoint
Identification of IL-6R as a potentially novel receptor of eCIRP in macr...
(A) RAW264.7 cells (1 × 106/mL) were stimulated with rmCIRP (1 μg/mL), and surface expression of IL-6R was assessed at 24 and 48 hours following rmCIRP treatment by flow cytometry. Data are expressed as mean ± SEM (n = 4 samples/group). Experiments were repeated, and the repeated experimental data are shown in Supplemental Figure 9. The groups were compared by 1-way ANOVA and SNK method (*P < 0.05 vs. PBS). (B) SPR (Biacore assay) was performed between rhCIRP and rhIL-6R. rhIL-6R as a ligand was immobilized on the chip. rhCIRP was injected as an analyte in concentrations of 0–1000 nM. The association and dissociation of analyte with ligand at the indicated concentration were recorded, and binding kinetics of rhCIRP and rhIL-6R was calculated. (C) Peritoneal macrophages (4 × 105/mL) were treated with rmCIPR (5 μg/mL) at 4°C for 10 minutes, immediately fixed with paraformaldehyde, and stained with rabbit anti-mouse CIRP Ab, goat anti–mouse IL-6R Ab, and goat anti–mouse CD11b Ab followed by Cy3-conjugated donkey anti–rabbit IgG and Cy5-conjugated donkey anti–goat IgG. The images were obtained by using a Zeiss confocal microscope under 63× objective. The colocalization of rmCIRP and IL-6R is indicated by the merged images (shown in yellow color). Scale bar: 20 μm. (D) After the staining protocol described in (C), cell-associated fluorescence was measured on a Biotek Synergy Neo2 at 579 nm upon excitation at 540 nm (E1), at 681 nm after excitation at 640 nm (E2), and at 681 nm after excitation at 540 nm (E3) for FRET unit calculation. The transfer of fluorescence was calculated as FRET units. FRET unit = (E3both − E3none) − ([E3Cy5 − E3none] × [E2both/E2Cy5]) − ([E3Cy3 − E3none] × [E1both/E1Cy3]). Data are expressed as mean ± SEM (n = 5–6 wells/group). Experiments were repeated 3 times. Groups compared by 2-tailed Student’s t test (*P < 0.01 vs. CD11b).

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts